Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line
| dc.contributor.author | Kanbur, Ertan | |
| dc.contributor.author | Baykal, Ahmet Tarik | |
| dc.contributor.author | Yerlikaya, Azmi | |
| dc.date.accessioned | 2025-10-16T15:18:48Z | |
| dc.date.issued | 2021 | |
| dc.identifier.doi | 10.1007/s12032-021-01563-1 | |
| dc.identifier.other | WOS:000682662200001 | |
| dc.identifier.uri | https://openaccess.acibadem.edu.tr/handle/11443/7220 | |
| dc.publisher | HUMANA PRESS INC | |
| dc.source | MEDICAL ONCOLOGY | |
| dc.subject | Bortezomib | |
| dc.subject | Prostate | |
| dc.subject | Cancer | |
| dc.subject | ERK | |
| dc.subject | LC3 | |
| dc.subject | CDK2 | |
| dc.subject | MELK | |
| dc.title | Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line | |
| dc.type | Article |
